2,579
+5.87%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Qol Holdings Co
Its shares trade on Tokyo Stock Exchange under the ticker 3034.T. It has been listed since 21 April 2006. In the fiscal year to 31 March 2026, it reported revenue of ¥290.77bn and net income of ¥7.41bn. At that date it held total assets of ¥158.12bn and shareholders' equity of ¥57.45bn.
Qol Holdings Co., Ltd. engages in the business process outsourcing (BPO) and pharmacy businesses. The company is headquartered in Minato-Ku, Tokyo-To. The company went IPO on 2006-04-21. The firm operates in two segments. The Insurance Pharmacy segment is engaged in the operation of insurance pharmacies, as well as the operation of convenience stores in hospitals. The BOP Commission segment is engaged in the Contract Sales Organization (CSO) business, Contract Research Organization (CRO) business, medical related business and the wholesale of medicine products, cosmetic products and daily necessities through its subsidiaries.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Consumer Staples Distribution & Retail
- Listed since
- 21 Apr 2006
- Employees
- 5,746
- Website
- qolhd.co.jp ↗
Leadership
Pay as last reported
- Mr. Takashi NakamuraPresident, Representative Director, since 2003
- Mr. Takayoshi IshiiSenior Managing Director, Representative Director, since 2015
- Mr. Kiyonobu FukumitsuManaging Director, Representative Director, since 2008
- Ms. Shinobu KarasawaManaging Director, President of Subsidiary, since 2010
- Ms. Yukari OnchiManaging Director, since 2004
- Mr. Kei ImaiDirector of Business Planning, Director, since 2024
- Mr. Yuji SuzukiDirector of Pharmacy Business Promotion Function, Director, since 2025
- Mr. Yutaka TogashiDirector of Human Resource Planning, Director, since 2012
- Mr. Kazuo IshiiDirector
- Ms. Toshiko KubokiIndependent Director
- Mr. Motoyuki MiyazakiIndependent Director
- Mr. Yasutoshi MoriIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- The company employs 5746 full-time staff members across its operations.
- The Insurance Pharmacy segment operates pharmacies within hospital facilities.
- The BOP Commission segment wholesales medicine and cosmetic products.
Weaknesses
- The company is headquartered in Minato-ku, Tokyo-To, Japan.
- The firm went public on 21 April 2006.
- The retail sector faces intense competition from other providers.
Opportunities
- The CRO business offers growth in medical research services.
- The CSO business expands contract sales organization capabilities.
- The wholesale of daily necessities increases product variety.
Threats
- Regulatory changes may impact insurance pharmacy operations significantly.
- Economic downturns could reduce consumer spending on cosmetics.
- Competitors might offer lower prices for wholesale goods.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.